Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1178904

registered interest
date	21/02/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pancreatic Cancer: Research
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will make it his policy to (a) allocate additional funding from the public purse to research on pancreatic cancer; (b) launch a campaign to help enable earlier identification of the symptoms of that cancer; and (c) ensure consistency in the application of treatment and care standards to people diagnosed with that cancer.
tabling member constituency	New Forest East
tabling member printed	Dr Julian Lewis
uin	18378
answer	answer is ministerial correction date of answer 26/02/2020 answer text <p>The Department invests £1 billion per year in health research through the National Institute for Health Research (NIHR). The NIHR does not allocate funding for specific disease areas. The following table shows the NIHR’s Programme funding for pancreatic cancer in each of the last three years.</p><table><tbody><tr><td><p>Year</p></td><td><p>2016/17</p></td><td><p>2017/18</p></td><td><p>2018/19</p></td><td><p>Total</p></td></tr><tr><td><p>NIHR Research Programmes total</p></td><td><p>£350,870</p></td><td><p>£411,444</p></td><td><p>£534,170</p></td><td><p>£1,296,484</p></td></tr></tbody></table><p> </p><p>In addition, the NIHR Clinical Research Network supported 62 studies over the last three years.</p><p>Several factors are considered when deciding which ‘Be Clear on Cancer’ (BCOC) campaigns to develop and run, with one of the main criteria being the scope to save lives through earlier diagnosis. This can only be effective through broad awareness campaigns if the cancer has a high enough incidence to be able to impact upon through marketing campaigns, as well as a clear early sign or symptom that the public can act upon should it arise.</p><p>In 2017, Public Health England (PHE) ran a pilot campaign in the East and West Midlands which focussed on a range of abdominal symptoms, such as diarrhoea, bloating and discomfort that can be indicative of several cancers, including pancreatic cancer. In 2017, PHE also ran a pilot campaign in the East and West Midlands which focussed on a range of abdominal symptoms, such as diarrhoea, bloating and discomfort that can be indicative of several cancers, including pancreatic cancer. Further information on the pilot is available at the following link:</p><p><a href="https://campaignresources.phe.gov.uk/resources/campaigns/16-be-clear-on-cancer/Abdominal%20Symptoms%20Regional%20Pilot" target="_blank">https://campaignresources.phe.gov.uk/resources/campaigns/16-be-clear-on-cancer/Abdominal%20Symptoms%20Regional%20Pilot</a></p><p>PHE is currently undertaking new data analysis and research to determine the future direction of BCOC activity.</p><p>Over the next three years every patient with cancer will receive a Personalised Care and Support Plan based on holistic needs assessment, end of treatment summaries and health and wellbeing information and support. All patients, including those with secondary cancers, will have access to the right expertise and support, including a Clinical Nurse Specialist or other support worker.</p><p> </p><p> </p><p> </p><p> </p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 26/02/2020 17:25:24 answering member 4380 label Biography information for Jo Churchill
tabling member	54 label Biography information for Sir Julian Lewis

1178962

registered interest
date	21/02/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Lung Diseases: Air Pollution
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps the Government is taking to tackle the effects poor air quality and pollution on lung health.
tabling member constituency	Coventry South
tabling member printed	Zarah Sultana
uin	18874
answer	answer is ministerial correction date of answer 02/03/2020 answer text <p>The Government’s Clean Air Strategy, published in January 2019, sets out an ambitious programme of action to reduce pollutant emissions from a wide range of sources including transport, industry, agriculture and domestic settings. These actions will reduce the impact of air pollution on human health. The Strategy sits alongside the 2017 UK Plan for Tackling Roadside Nitrogen Dioxide Concentrations, which focuses on reducing emissions from road transport.</p><p>The Government’s proposed Environment Bill, reintroduced on 30 January, will deliver key aspects of the Strategy and includes a commitment to set a legally binding target for PM2.5, with the aim of driving action to reduce long-term exposure to fine particulate matter, which impacts on human health, including lung health.</p><p>Public Health England works closely with the Department for Environment, Food and Rural Affairs to provide alerts and advice during high air pollution episodes to ensure that key health messages are communicated to vulnerable groups, including those with existing lung conditions.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 02/03/2020 15:40:30 answering member 4380 label Biography information for Jo Churchill
tabling member	4786 label Biography information for Zarah Sultana

1179064

registered interest
date	21/02/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes: Medical Equipment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what progress he has made on securing the adequate availability and delivery of freestyle librelink diabetic sensors during the transition period.
tabling member constituency	Southport
tabling member printed	Damien Moore
uin	18916
answer	answer is ministerial correction date of answer 02/03/2020 answer text <p>The Department is aware that there has been a temporary disruption in the supply of Freestyle Libre glucose monitoring sensors, caused by an increase in demand. The supplier, Abbott, has however recently informed us that the delay issues have now been fully resolved and that this news has been communicated to existing users and health care professionals.</p><p>Abbott have emphasised that the supply disruption was not caused by the United Kingdom leaving the European Union. The UK has now left the EU and entered a transition period, which will run until 31 December 2020. EU regulations on medicines, vaccines and medical devices will continue to apply to the UK throughout the transition period, during which we will negotiate a new trade agreement with the EU.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 02/03/2020 13:18:06 answering member 4380 label Biography information for Jo Churchill
tabling member	4669 label Biography information for Damien Moore

1179077

registered interest
date	21/02/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pancreatic Cancer: Research
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what funding from the public purse has been allocated to research into pancreatic cancer in each of the last three years; what progress has been made on the early diagnosis of pancreatic cancer; for what reasons pancreatic cancer patients in the UK have lower rates for surviving five years after diagnosis compared with other European countries; and if he will make a statement.
tabling member constituency	New Forest East
tabling member printed	Dr Julian Lewis
uin	18427
answer	answer is ministerial correction date of answer 27/02/2020 answer text <p>The Department invests £1 billion per year in health research through the National Institute for Health Research (NIHR). As with other Government funders of health research, the NIHR does not allocate funding for specific disease areas. The level of research spend in a particular area, is driven by factors including scientific potential and the number and scale of successful funding applications.</p><p>Early diagnosis rates for pancreatic cancer increased by 2.9 percentage points between 2014 and 2017, from 21.0% to 23.9%, and improving early diagnosis of cancer is a top priority for the NHS. One of the core ambitions in the NHS Long Term Plan is to diagnose 75% of cancers at stage 1 or 2 by 2028 to save 55,000 lives a year. Cancer Alliances in England are using the Rapid Diagnostic Cancer model to improve the diagnostic experience for patients who are suspected of having particular cancers including pancreatic cancer.</p><p>United Kingdom survival rates for cancer have never been higher and continue to improve, but there is more work to do to boost survival for all cancers. However, the rates of five year survival for pancreatic cancer are unfortunately very low everywhere. The rates in England (4%) are below the reported average in Europe (6%). The differences between countries may reflect differences in cancer biology, varying availability of diagnostic tests, the stage at diagnosis and data collection practices. Access to computed tomography scanning (the most commonly-used diagnostic test) is important which is why the Government recently announced £200 million to upgrade cancer diagnostic equipment in England.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 27/02/2020 17:22:48 answering member 4380 label Biography information for Jo Churchill
tabling member	54 label Biography information for Sir Julian Lewis

1179078

registered interest
date	21/02/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pancreatic Cancer: Research
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what criteria are applied in determining the level of funding of research into pancreatic cancer relative to investment in research into other types of cancer; what assessment has been made of the prognosis for surviving pancreatic cancer relative to that for surviving other types of cancer; and what assessment he has made of whether pancreatic cancer survival rates would be improved by (a) greater public awareness of its symptoms and (b) earlier diagnosis of the disease.
tabling member constituency	New Forest East
tabling member printed	Dr Julian Lewis
uin	18428
answer	answer is ministerial correction date of answer 27/02/2020 answer text <p>The Department invests £1 billion per year in health research through the National Institute for Health Research (NIHR). The NIHR welcomes funding applications for research into any aspect of human health, including pancreatic cancer. As with other Government funders of health research, the NIHR does not allocate funding for specific disease areas. The level of research spend in a particular area, is driven by factors including scientific potential and the number and scale of successful funding applications.</p><p>United Kingdom survival rates for cancer have never been higher and continue to improve, but there is more work to do to boost survival for all cancers. The rates of five year survival for pancreatic cancer are unfortunately very low everywhere.</p><p>Improving early diagnosis of cancer is key for cancer survival, and is a priority for this Government. In October 2018, the Government announced a package of measures that will be rolled out across the country with the aim of seeing three quarters of all cancers detected at an early stage by 2028. The early diagnosis ambition includes rare and less common cancers and those that are less survivable, such as pancreatic cancer. Success cannot realistically be achieved without making progress on these cancers. Early diagnosis rates for pancreatic cancer increased by 2.9 percentage points between 2014 and 2017, from 21.0% to 23.9%.</p><p>NHS England is establishing Rapid Diagnostic Centres (RDCs) across the country to bring together the latest diagnostic equipment and expertise. This programme builds on the Multidisciplinary Diagnostic Centre model piloted through the Accelerate, Coordinate and Evaluate programme, which focussed on diagnosing cancers where patients often present with non-specific symptoms and may go to their general practitioner many times before being sent for appropriate tests.</p><p>Cancer Alliances are using the RDC model to improve the diagnostic experience for patients who are suspected of having particular cancers including pancreatic, head and neck, and skin cancers.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 27/02/2020 17:28:25 answering member 4380 label Biography information for Jo Churchill
tabling member	54 label Biography information for Sir Julian Lewis

1179079

registered interest
date	21/02/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pancreatic Cancer: Research
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will make it his policy to (a) increase investment in research into pancreatic cancer, (b) establish a dedicated awareness campaign to enable the earlier identification of the symptoms of pancreatic cancer and (c) improve consistency in the application of treatment and care standards for patients diagnosed with pancreatic cancer.
tabling member constituency	New Forest East
tabling member printed	Dr Julian Lewis
uin	18429
answer	answer is ministerial correction date of answer 02/03/2020 answer text <p>The Department invests £1 billion per year in health research through the National Institute for Health Research (NIHR). The NIHR does not allocate funding for specific disease areas. The following table shows the NIHR’s Programme funding for pancreatic cancer in each of the last three years:</p><table><tbody><tr><td><p>Year</p></td><td><p>2016/17</p></td><td><p>2017/18</p></td><td><p>2018/19</p></td><td><p>Total</p></td></tr><tr><td><p>NIHR Research Programmes total</p></td><td><p>£350,870</p></td><td><p>£411,444</p></td><td><p>£534,170</p></td><td><p>£1,296,484</p></td></tr></tbody></table><p> </p><p>In addition, the NIHR Clinical Research Network supported 62 studies over the last three years.</p><p>Several factors are considered when deciding which ‘Be Clear On Cancer’ (BCOC) campaigns to develop and run, with one of the main criteria being the scope to save lives through earlier diagnosis. This can only be effective through broad awareness campaigns if the cancer has a high enough incidence to be able to impact upon through marketing campaigns, as well as a clear early sign or symptom that the public can act upon should it arise.</p><p>In 2017, Public Health England (PHE) also ran a pilot campaign in the East and West Midlands which focussed on a range of abdominal symptoms, such as diarrhoea, bloating and discomfort that can be indicative of several cancers, including pancreatic cancer. Further information on the pilot is available at the following link:</p><p><a href="https://campaignresources.phe.gov.uk/resources/campaigns/16-be-clear-on-cancer/Abdominal%20Symptoms%20Regional%20Pilot" target="_blank">https://campaignresources.phe.gov.uk/resources/campaigns/16-be-clear-on-cancer/Abdominal%20Symptoms%20Regional%20Pilot</a></p><p>PHE is currently undertaking new data analysis and research to determine the future direction of BCOC activity.</p><p>Over the next three years every patient with cancer will receive a Personalised Care and Support Plan based on holistic needs assessment, end of treatment summaries and health and wellbeing information and support. All patients, including those with secondary cancers, will have access to the right expertise and support, including a Clinical Nurse Specialist or other support worker.</p><p> </p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 02/03/2020 13:30:27 answering member 4380 label Biography information for Jo Churchill
tabling member	54 label Biography information for Sir Julian Lewis

1179091

registered interest
date	21/02/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Sutton Coldfield
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent steps his Department has taken to reduce waiting times for NHS hospital appointments for cancer patients in Sutton Coldfield constituency.
tabling member constituency	Sutton Coldfield
tabling member printed	Mr Andrew Mitchell
uin	18444
answer	answer is ministerial correction date of answer 02/03/2020 answer text <p>There is an ongoing improvement programme focussing on the main cancer waiting time standards and pathways across Birmingham and Solihull. This, along with a number of initiatives funded by the West Midlands Cancer Alliance and transformation funding, aims to improve waiting times and patient experience and includes:</p><p>- introduction of the Faecal Immunochemical Test for bowel cancer screening; and</p><p>- implementation of a vague symptom pathway through a Rapid Diagnostic Centre.</p><p>Weekly oversight and assurance meetings are led by the Chief Operating Officer of University Hospitals Birmingham NHS Foundation Trust with all specialities attending. NHS Birmingham and Solihull Clinical Commissioning Group continues to meet with the Trust each month to explore all avenues, including developing a trajectory for improving performance and waiting times.</p><p> </p><p> </p><p> </p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 02/03/2020 13:19:52 answering member 4380 label Biography information for Jo Churchill
tabling member	1211 label Biography information for Mr Andrew Mitchell

1179105

registered interest
date	21/02/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	General Practitioners: Houghton and Sunderland South
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many full-time equivalent clinical staff there were in each GP practice in Houghton and Sunderland South constituency in 2018-19.
tabling member constituency	Houghton and Sunderland South
tabling member printed	Bridget Phillipson
uin	18676
answer	answer is ministerial correction date of answer 26/02/2020 answer text <p>The data is not available in the format requested.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 26/02/2020 17:27:06 answering member 4380 label Biography information for Jo Churchill
tabling member	4046 label Biography information for Bridget Phillipson

1179143

registered interest
date	21/02/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Energy Drinks: Children
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will bring forward legislative proposals to restrict the sale of energy drinks to people aged under 16.
tabling member constituency	Washington and Sunderland West
tabling member printed	Mrs Sharon Hodgson
uin	18528
answer	answer is ministerial correction date of answer 02/03/2020 answer text <p>The Government confirmed it will end the sale of energy drinks to children under the age of 16 in chapter three of the childhood obesity plan, published in July 2019 as part of ‘Advancing our health: prevention in the 2020s’. We will be setting out the full policy in our consultation response as soon as possible.</p><p> </p><p> </p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 02/03/2020 15:37:00 answering member 4380 label Biography information for Jo Churchill
tabling member	1521 label Biography information for Mrs Sharon Hodgson

1179144

registered interest
date	21/02/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Flour: Folic Acid
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what progress has been made on the consultation on the fortification of flour.
tabling member constituency	Washington and Sunderland West
tabling member printed	Mrs Sharon Hodgson
uin	18529
answer	answer is ministerial correction date of answer 02/03/2020 answer text <p>I refer the hon. Member to the answer I gave to the hon. Member for Newport East (Jessica Morden MP) on 4 February 2020 to Question <a href="https://www.parliament.uk/business/publications/written-questions-answers-statements/written-question/Commons/2020-01-30/10331/" target="_blank">10331</a>.</p><p> </p><p> </p><p> </p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 02/03/2020 15:39:37 answering member 4380 label Biography information for Jo Churchill
tabling member	1521 label Biography information for Mrs Sharon Hodgson